1117-AB09 201004 Unified Agenda of Federal Regulatory and Deregulatory Actions 1117 Drug Enforcement Administration DEA 1100 Department of Justice DOJ Registration Requirements for Importers and Manufactures of Prescription Drug Products Containing Ephedrine, Pseudoephedrine, or Phenylpropanolamine Other Significant Previously Published in The Unified Agenda Completed Actions No No 21 CFR 1309 21 USC 821 to 824 21 USC 830 21 USC 871(b) 21 USC 875 21 USC 877 21 USC 958 No NPRM 01/18/2008 73 FR 3432 NPRM Comment Period End 03/18/2008 Final Action 02/01/2010 75 FR 4973 Final Action Effective 03/03/2010 Docket DEA-294 No No None No No www.regulations.gov No No 1117-AB08 Related to Mark Caverly W. 1117 Drug Enforcement Administration DEA 202 307-7297 dea.diversion.policy@usdoj.gov 8701 Morrissette Drive, Springfield VA 22152